Inclusion Criteria:  Subjects must have the ability to speak, read and understand English. Ability to understand and agree to contents of informed consent either in writing or verbally. Age 55 or older at the Enrollment Visit.  Adults diagnosed with NV-AMD in at least one eye based on the subject's medical record. Fellow eyes diagnosed with dry AMD may be included as secondary eyes to a primary eye diagnosed with NV-AMD.  Note: eyes whit other pathologies including pseudocysts, outer retinal tabulations, pigments epithelial, detachments, hemorrhage, sub retinal hyper reflective material (SHRM), geographic atrophy and sub RPE, hypo reflective areas can be enrolled.  Best corrected Visual Acuity of 20/320 or better in eyes that will perform self-imaging. Available and willing to set up a device and conduct self-imaging at their home.  Exclusion Criteria:  Anti-VEGF treatment for NV-AMD in the study eye(s) at the screening visit. Any other retinal disease requiring steroidal or anti-VEGF injections. Prior experience with the NVHO device.